These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 10674197

  • 1. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone.
    McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Volkmar FR, Votolato NA, Walson P.
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):201-24. PubMed ID: 10674197
    [Abstract] [Full Text] [Related]

  • 2. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A, Gonnier V, Aussilloux C.
    Encephale; 2002 Jan; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
    Troost PW, Lahuis BE, Steenhuis MP, Ketelaars CE, Buitelaar JK, van Engeland H, Scahill L, Minderaa RB, Hoekstra PJ.
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
    [Abstract] [Full Text] [Related]

  • 4. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [Abstract] [Full Text] [Related]

  • 5. Role of risperidone in children with autism spectrum disorder.
    Chavez B, Chavez-Brown M, Rey JA.
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [Abstract] [Full Text] [Related]

  • 6. Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.
    Malone RP, Maislin G, Choudhury MS, Gifford C, Delaney MA.
    J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2):140-7. PubMed ID: 11837403
    [Abstract] [Full Text] [Related]

  • 7. Risperidone use in the treatment of behavioral symptoms in children with autism.
    West L, Waldrop J.
    Pediatr Nurs; 2006 Feb; 32(6):545-9. PubMed ID: 17256292
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [Abstract] [Full Text] [Related]

  • 11. An open clinical trial of risperidone monotherapy in young children with autistic disorder.
    Findling RL, Maxwell K, Wiznitzer M.
    Psychopharmacol Bull; 1997 Nov; 33(1):155-9. PubMed ID: 9133768
    [Abstract] [Full Text] [Related]

  • 12. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA, McDougle CJ.
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [Abstract] [Full Text] [Related]

  • 13. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S, Fallah J, Mohammadi MR, Imani R, Mohammadi M, Salehi B, Ghanizadeh A, Raznahan M, Mohebbi-Rasa S, Rezazadeh SA, Forghani S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb 01; 34(1):32-6. PubMed ID: 19772883
    [Abstract] [Full Text] [Related]

  • 14. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.
    Correia CT, Almeida JP, Santos PE, Sequeira AF, Marques CE, Miguel TS, Abreu RL, Oliveira GG, Vicente AM.
    Pharmacogenomics J; 2010 Oct 01; 10(5):418-30. PubMed ID: 19997080
    [Abstract] [Full Text] [Related]

  • 15. [Risperidone use in child and adolescent psychiatric patients].
    Chevreuil C, Reymann JM, Frémaux T, Polard E, Séveno T, Bentué-Ferrer D.
    Therapie; 2008 Oct 01; 63(5):359-75. PubMed ID: 19154706
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders.
    McDougle CJ, Holmes JP, Carlson DC, Pelton GH, Cohen DJ, Price LH.
    Arch Gen Psychiatry; 1998 Jul 01; 55(7):633-41. PubMed ID: 9672054
    [Abstract] [Full Text] [Related]

  • 17. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 01; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology.
    McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B.
    Am J Psychiatry; 2005 Jun 01; 162(6):1142-8. PubMed ID: 15930063
    [Abstract] [Full Text] [Related]

  • 20. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study.
    Lindsay RL, Eugene Arnold L, Aman MG, Vitiello B, Posey DJ, McDougle CJ, Scahill L, Pachler M, McCracken JT, Tierney E, Bozzolo D.
    J Intellect Dev Disabil; 2006 Dec 01; 31(4):204-9. PubMed ID: 17178532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.